About GEMVI
GEMVI is a multidisciplinary reflection group on menopause and hormonal aging that is led by a Scientific Committee of 25 members, from 9 medical or surgical specialties, chosen for their recognized and complementary competence in the field of menopause.
The objectives of the GEMVI concern the medical profession, health professionals, public authorities, the media and the general public with the aim of:
- Dissemination of the facts established in the field of menopause, hormonal aging of men and women and their consequences on health and quality of life, as well as current and future advances in diagnosis and management.
- Training and medical research on these themes.
- Participation and scientific exchanges with European and world experts in these same themes.
The actions of GEMVI are coordinated by an Executive Board of 9 members from the Scientific Committee and currently chaired by Professor Patrice Lopès. The creation of GEMVI benefited from the sponsorship and support of the French National College of Obstetrician Gynecologists (CNGOF) and the National Federation of Colleges of Medical Gynecology (FNCGM). A representative of these learned societies is in fact an ex officio member of the Executive Board of the GEMVI (Pr. Léon Boubli for the CNGOF and Dr. Brigitte Letombe for the FNCGM).
Contact Email: Click here to go to the Contact form on the GEMVI website
Website: http://gemvi.org/
Upcoming Events
Save the Date: The 14th Annual Congress of GEMVI will take place in Paris on 15th and 16th November 2024.
Executive
President
Professor Florence Trémollières
General Secretary
Professor Geneviève Plu-Bureau
Treasurer
Professor Patrice Lopes
Vice-president
Dr Gabriel André
CAMS / International Relations
Professor Anne Gompel
Dr Brigitte Letombe
Professor Léon Boubli
Professor Claude Hocke
Dr. Brigitte Raccah-Tebeka
Educational resources
- Presentations (members only): Etiologies of premature ovarian failure, Diagnosis of premature ovarian failure (IOP) and action, What genetic assessment should be performed in patients with IOP? and lots more.
- Patient Information Sheets: Menopause and THM, Perimenopause, Menopause Disorders and lots more.
News
- Can hormone therapy prevent Alzheimer’s disease in women at risk?
- A new controversy on THM without foundation…
- CPR Menopause 2021
- VIEW GEMVi WEBINARS
View these and other news items on the GEMVI website.
Join GEMVI
Click here for the online application: Become a member – GEMVI